Latest News
Nota AI and SiMa.ai Sign Strategic Partnership for Physical AI Technology Collaboration
"Combining AI Optimization with High Performance and Efficiency MLSoCs to Lead the Physical AI Market" * Nota AI's AI Optimization Technology Meets SiMa.ai's MLSoC™ Product Family, Maximizing On-Device AI Performance for Physical AI * Joint Development and Commercialization of AI Solutions fo...
2026-03-25 20:00
6821
AOTOS Launches the World's First Wheelie-Capable E-Moto: The Flux X26 on Kickstarter
NEW YORK, March 25, 2026 /PRNewswire/ -- AOTOS, a global pioneer in Human Mobility Robotics, has officially launched its flagship product on Kickstarter, the Flux X26 and X26 Pro. Representing the first physical manifestation of the company's vision, the Flux X26 is designed to bridge the gap bet...
2026-03-25 20:00
4586
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the...
2026-03-25 20:00
5336
Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results
BEIJING, March 25, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. ...
2026-03-25 19:57
6397
51Talk Online Education Group to Report Fourth Quarter and Full Year 2025 Financial Results on Friday, March 27, 2026
Earnings Call Scheduled for 8:00 a.m. ET on March 27, 2026 SINGAPORE, March 25, 2026 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that it will report i...
2026-03-25 19:20
7175
Tantech Holdings Ltd Announces Notice of Allowance from U.S. Patent and Trademark Office for Hanging Cabinet Design Patent
LISHUI, China, March 25, 2026 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) (the "Company" or "Tantech"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) for a Hanging Cabinet d...
2026-03-25 18:30
5907
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual results for 2025, demonstrating record growth and a transformative leap in operational sophistication. Th...
2026-03-25 18:22
6736
Segway Powersports Debuts Super Villain at The Mint 400 with P3 Podium Finish
MCKINNEY, Texas, March 25, 2026 /PRNewswire/ -- Segway Powersports, a global innovator in intelligent off-road vehicles and connected riding systems, celebrated a triumphant debut at the legendary Mint 400, the iconic Las Vegas desert race and a key event in the American Off-Road Racing Champions...
2026-03-25 18:13
4864
HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering
Listing milestone positions HanchorBio to strengthen institutional visibility, advance itsFBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases TAIPEI, SHANGHAI and SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a globa...
2026-03-25 18:00
6004
VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
* Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 * A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment * Fully biological transplant eliminates need for immunosuppres...
2026-03-25 17:11
4329
DouYu International Holdings Limited Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
WUHAN, China, March 25, 2026 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced its unaudited financial results for the fourth quarter and...
2026-03-25 17:00
5621
SHEIN Expands Sustainable Aviation Fuel Pilot Initiatives, Signs Agreement with DHL for GoGreen Plus Service
SINGAPORE, March 25, 2026 /PRNewswire/ -- SHEIN, a global online fashion and lifestyle retailer, has signed an agreement with DHL to adopt its GoGreen Plus service, supporting the use of sustainable aviation fuel (SAF) within air cargo logistics. The collaboration forms part of SHEIN's broader ef...
2026-03-25 15:10
6539
BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States
BGM0504 shown to be generally well tolerated Overall safety, pk, and efficacy profile supports once-daily oral dosing SUZHOU, China, March 25, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (SSE: 688166, "BrightGene" or "the Company") today announced positive topline results f...
2026-03-25 14:32
4805
How China maps out a strong start for 15th Five-Year Plan
BEIJING, March 25, 2026 /PRNewswire/ -- This is a report from Xinhua News Agency: How China maps out a strong start for 15th Five-Year Plan Five-year plans are China's medium- and long-term development blueprints formulated in five-year cycles, and they embody the key to China's governance su...
2026-03-25 14:27
4011
ZNSHINE SOLAR Supplies Modules for Cherry Valley I PV Project in the United States
CHERRY VALLEY, Ark., March 25, 2026 /PRNewswire/ -- ZNSHINE SOLAR, a globally recognized Tier 1 photovoltaic manufacturer, has announced its contribution of 155.735 MW of high-efficiency modules to the 185.035 MW (DC) Cherry Valley I PV Project in Cherry Valley, Arkansas. The project has an AC ca...
2026-03-25 12:12
4493
Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
HONG KONG, March 24, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to initiate Phase II clinical trials for AK146D1, a first...
2026-03-25 10:40
6491
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson's Disease
BEIJING, March 24, 2026 /PRNewswire/ -- A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic efficacy in Parkinson's disease...
2026-03-25 10:34
4533
Money talks: investor turnout to set record
BEIJING, March 24, 2026 /PRNewswire/ -- This is a news report from China Daily:
The 2026 ZGC International Technology Trade Fair is set to open on Wednesday
afternoon, poised to achieve its highest-ever investor turnout.
2026-03-25 10:13
4892
Hanwha Power Systems and PSM unite as Hanwha Power, a global compressor and gas turbine business
The combined company will accelerate its expansion into global energy markets, including power plants and data centers. SEOUL, South Korea, March 24, 2026 /PRNewswire/ -- Hanwha Impact's subsidiaries, Hanwha Power Systems and PSM (Power Systems Mfg., LLC), a U.S.-based gas turbine service compan...
2026-03-25 08:23
6644
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis
SHANGHAI, March 24, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class monoclonal antibody with global rights, for the treatm...
2026-03-25 08:08
5870
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 294 media titles]
2026-09-24 10:30
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 281 media titles]
2026-09-23 09:00
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 276 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 276 media titles]
2026-09-29 09:00
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
13256
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
11988
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
10920
